Search Results - "Pavel, Petra"
-
1
PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming
Published in International journal of molecular sciences (08-07-2021)“…Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors expressed in the skin. Three PPAR isotypes, α (NRC1C1), β or δ (NRC1C2) and γ…”
Get full text
Journal Article -
2
Atopic Dermatitis: The Fate of the Fat
Published in International journal of molecular sciences (14-02-2022)“…Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease in which dry and itchy skin may develop into skin lesions. AD has a strong genetic…”
Get full text
Journal Article -
3
Xenobiotic Receptors and Their Mates in Atopic Dermatitis
Published in International journal of molecular sciences (29-08-2019)“…Atopic dermatitis (AD) is the most common inflammatory skin disease worldwide. It is a chronic, relapsing and pruritic skin disorder which results from…”
Get full text
Journal Article -
4
Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients
Published in Haematologica (Roma) (01-12-2023)“…Clonal hematopoiesis (CH) is an age-related condition driven by stem and progenitor cells harboring recurrent mutations linked to myeloid neoplasms. Currently,…”
Get full text
Journal Article -
5
Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL
Published in Cells (Basel, Switzerland) (15-05-2020)“…T lymphocyte collection through leukapheresis is an essential step for chimeric antigen receptor T (CAR-T) cell therapy. Timing of apheresis is challenging in…”
Get full text
Journal Article -
6
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
Published in Journal of hematology and oncology (22-07-2023)“…Third-generation chimeric antigen receptor (CAR)-engineered T cells (CARTs) might improve clinical outcome of patients with B cell malignancies. This is the…”
Get full text
Journal Article -
7
Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution
Published in BMC cancer (25-04-2020)“…High-dose (HD) chemotherapy followed by autologous blood stem-cell transplantation (ASCT) is the standard treatment for multiple myeloma (MM) patients…”
Get full text
Journal Article -
8
3D-Organotypic Cultures to Unravel Molecular and Cellular Abnormalities in Atopic Dermatitis and Ichthyosis Vulgaris
Published in Cells (Basel, Switzerland) (22-05-2019)“…Atopic dermatitis (AD) is characterized by dry and itchy skin evolving into disseminated skin lesions. AD is believed to result from a primary acquired or a…”
Get full text
Journal Article -
9
Peroxisomal Fatty Acid Oxidation and Glycolysis Are Triggered in Mouse Models of Lesional Atopic Dermatitis
Published in JID innovations (01-09-2021)“…Alterations of the lipid profile of the stratum corneum have an important role in the pathogenesis of atopic dermatitis (AD) because they contribute to…”
Get full text
Journal Article -
10
A Freezing Protocol for Hematopoietic Stem Cells
Published in Methods in molecular biology (Clifton, N.J.) (01-01-2019)“…Especially in the field of autologous transplantation, it has been found necessary to develop methods that ensure long-term storage with maintenance of…”
Get more information
Journal Article -
11
Excessive Production of Hydrogen Peroxide in Mitochondria Contributes to Atopic Dermatitis
Published in Journal of investigative dermatology (01-10-2023)“…Atopic dermatitis (AD) is a complex disease characterized by chronic recurring eczema and pruritus. In addition, patients with AD display increased cutaneous…”
Get full text
Journal Article -
12
The First Real-World Experience with Betibeglogene Autotemcel (beti-cel) Gene Therapy Treatment for Transfusion-Dependent β-Thalassemia (TDT)
Published in Blood (23-11-2021)“…Background Beti-cel ex vivo gene therapy integrates a modified HBB gene into hematopoietic stem cells of patients with TDT, aiming to enable lifelong, stable…”
Get full text
Journal Article -
13
Mitochondrial Activity Is Upregulated in Nonlesional Atopic Dermatitis and Amenable to Therapeutic Intervention
Published in Journal of investigative dermatology (01-10-2022)“…Previous work has shown increased expression of genes related to oxidative stress in nonlesional atopic dermatitis (ADNL) skin. Although mitochondria are key…”
Get full text
Journal Article -
14
Standardization of Good Manufacturing Practice–compliant production of bone marrow–derived human mesenchymal stromal cells for immunotherapeutic applications
Published in Cytotherapy (Oxford, England) (01-02-2015)“…Abstract Background aims Human mesenchymal stem or stromal cells (MSCs) represent a potential resource not only for regenerative medicine but also for…”
Get full text
Journal Article -
15
Third-Generation Chimeric Antigen Receptor (CAR) T Cells in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin Lymphoma (NHL) - Results from the Heidelberg Trial 1 (HD-CAR-1 trial)
Published in Blood (23-11-2021)“…Introduction Chimeric antigen receptor (CAR) T cell (CART) therapy has shown to be a new and very promising therapeutical method in patients with relapsed or…”
Get full text
Journal Article -
16
Low-dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease
Published in European journal of haematology (01-07-2016)“…For patients with severe and refractory autoimmune diseases, high‐dose chemotherapy and autologous hematopoietic stem cell transplantation has been established…”
Get full text
Journal Article -
17
Comparison between intermittent and continuous spectra optia leukapheresis systems for autologous peripheral blood stem cell collection
Published in Journal of clinical apheresis (01-02-2017)“…Terumo BCT recently introduced a new system for mononuclear cell (MNC) collection that uses a Spectra Optia apheresis machine equipped with a redesigned…”
Get full text
Journal Article -
18
Gene Therapy in Transfusion-Dependent Non-β0/β0 Genotype β-Thalassemia: First Real-World Experience of Beti-cel
Published in Blood advances (17-10-2024)“…Gene addition and editing strategies for transfusion-dependent β-thalassemia have gained momentum as potentially curative treatment options, with studies…”
Get full text
Journal Article -
19
Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma
Published in Transfusion (Philadelphia, Pa.) (01-10-2017)“…BACKGROUND Granulocyte–colony‐stimulating factor (G‐CSF) originators such as filgrastim (Neupogen) and lenograstim (Granocyte) are widely used for peripheral…”
Get full text
Journal Article -
20
Cryostorage to What End? – Autologous Stem Cell Products in Burkitt Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Myeloproliferative Neoplasm Patients
Published in Transfusion medicine and hemotherapy (01-03-2021)“…Introduction: Recently, we identified a huge discrepancy between the collection practice and the actual utilization of cryopreserved peripheral blood stem…”
Get full text
Journal Article